CD40 receptor agonist mAbs (Bioceros)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCD40 receptor agonist mAbs (Bioceros)
Drug Alias NameCD40 receptor agonist antibody (PanGenetics)CD40 receptor agonist antibody (PanGenetics)CD40 costimulator (PanGenetics/Bioceros)PG-120
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonists
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsAutoimmune DiseasesLymphoma, B-CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPangenetics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPangeneticsBioceros
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesLymphoma, B-CellNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A